SalaryGuide
AboutPricingFor Employers

Marketing jobs

1 marketing jobs

GeneDx logo
7 weeks ago

Social Media Manager

GeneDx

USA (Remote)Internship$125K/yr – $138K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

1 jobs
GeneDx logo

Social Media Manager

GeneDx

USA (Remote)

$125K/yr - $138K/yrIn-houseInternshipMid level5+ years exp.
7 weeks ago
GeneDx logo
GeneDx

Social Media Manager

USA (Remote)

$125K/yr – $138K/yrMid Level5+ years expInternship

Posted 7 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own social strategy and storytelling for a regulated-healthcare audience, driving goals, competitive differentiation, and leadership-aligned metrics across strategy, content publishing, and engagement.

  • Social Strategy: Own the platform mix, trend spotting, and goal setting to differentiate GeneDx and guide leadership on social investments.
  • Content & Publishing: Own the organic social calendar, messaging in partnership with Creative, and testing content to lift reach and brand recognition.
  • Storytelling & Community: Own social storytelling opportunities, cross-functional storytelling, and active listening to surface patient/provider stories and manage risk signals.

Job Description

Responsibilities

  • Social strategy and competitive analysis – 20%: Support the GeneDx social media strategy to meet company short- and long-term goals, including determining how to best use resources and how to stand apart from competitors.
  • Social strategy and competitive analysis – 20%: Set and report on monthly and quarterly social media goals aligned to the company’s social media strategy, while improving internal processes to increase efficiency.
  • Social strategy and competitive analysis – 20%: Identify and share platform and industry trends, providing recommendations and guidance to others on the marketing and leadership team.
  • Social strategy and competitive analysis – 20%: Monitor competitor activity and emerging healthcare, biotech, and social media trends to identify opportunities for differentiation and innovation.
  • Social media content creation, publishing and calendar management – 50%: Conceptualize and write effective organic social posts that grab attention, engage platform users, and improve brand recognition, while ensuring alignment with existing corporate and client-facing messaging.
  • Social media content creation, publishing and calendar management – 50%: Design, develop, implement, and manage the organic social publishing calendar, ensuring we publish the right content at the right time.
  • Social media content creation, publishing and calendar management – 50%: Coordinate publishing timelines across campaigns, launches, awareness moments, and corporate initiatives.
  • Social media content creation, publishing and calendar management – 50%: In partnership with Creative team, lead on messaging and develop social media creative that aligns with organizational objectives, using tools to organize and track activities.
  • Social media content creation, publishing and calendar management – 50%: Test, measure, and improve the effectiveness of social content, recommending creative iterations to optimize performance and help achieve business goals.
  • Social media content creation, publishing and calendar management – 50%: Develop, implement, manage, and replenish our social content library, identifying message gaps and exploring new and dynamic formats and visuals (e.g., polls, infographics, videos, carousels).
  • Social media content creation, publishing and calendar management – 50%: Manage and grow the GeneDx LinkedIn newsletter strategy, including editorial planning, content development, publishing, and performance tracking.

Nice-to-have

  • Experience in the healthcare industry and/or in a regulated environment (desired but not required)
  • B2B experience desired

Benefits

  • Paid Time Off (PTO)
  • Health, Dental, Vision and Life insurance
  • 401k Retirement Savings Plan
  • Employee Stock Purchase Plan
  • Employee Discounts
  • Voluntary benefits
  • Programs for parents and parents-to-be
  • We provide expert support for family planning, pregnancy, and postpartum care, including up to 22 weeks of fully paid parental leave (U.S.) and up to $25K annually for fertility, adoption, or surrogacy.
GeneDx logo

GeneDx

2.5 Glassdoor

We see a world where every genetic condition is understood, and every patient receives the care they need to live their fullest life. Our approach to genetic testing, along with having one of the world's most diverse rare disease data sets, makes us a catalyst for clear, connected and actionable care.Named one of Fast Company's Most Innovative Companies of 2025, we're leading the way to a future where we end the diagnostic odyssey. It all begins with a single test.

Founded in 2000
Stamford, Connecticut, USA
1.1K employees (49 in marketing)
www.genedx.com
27% recommend to a friend
47% CEO approval

Traffic Signals

Monthly Visitors
92.8K
Monthly Google Ads Budget
$2.9K
Traffic Source Mix
Search
31.7%
Direct
50.4%
Referral
5.8%
Social
11.4%
Paid
0.6%

Headcount Trend

Current headcount: ~1.1K

Marketing Team

Marketing Team Size
30 (3% of company)
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$941M
Last Raise
$150M
Post IPO Equity, 3 years ago

Funding History

  • Jan 2023
    Post IPO Equity • $150M
  • Jan 2022
    Post IPO Equity • $200M
  • Jul 2021
    Post IPO Equity • $350M

Recent News

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
Nov 6, 2025 • Yahoo Finance
Howard McLeod Started a New Position as Senior Vice President of Clinical Affairs at GeneDx
Nov 6, 2025 • Oncodaily
GeneDx to Participate in Upcoming Investor Conferences
Nov 4, 2025 • Business Wire
GeneDx (WGS) One-Off $14.5M Loss Raises Questions Despite Strong Growth Outlook
Oct 29, 2025 • simplywall.st
GeneDx Holdings Corp. (WGS) Q3 Earnings and Revenues Surpass Estimates
Oct 28, 2025 • Yahoo Finance
Earnings call transcript: GeneDx beats Q3 2025 EPS forecast
Oct 28, 2025 • Investing.com
GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth (NASDAQ:WGS)
Oct 27, 2025 • Seeking Alpha
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
Oct 22, 2025 • Business Wire
FDA grants Breakthrough Device Designation to GeneDx genomic tests
Oct 20, 2025 • Medical Economics
FDA grants breakthrough device status to GeneDx genomic tests
Oct 20, 2025 • Investing.com
GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing
Oct 20, 2025 • Business Wire
Illumina’s constellation tech shows promise in GeneDx rare disease study
Oct 15, 2025 • Investing.com
GeneDx's Blueprint For The Next Healthcare Revolution
Oct 15, 2025 • Seeking Alpha
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Oct 15, 2025 • PR Newswire
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
Oct 14, 2025 • Business Wire
GeneDx (WGS): Evaluating Valuation After Landmark Newborn Genomics Contract with Florida State University
Oct 14, 2025 • Yahoo Finance
GeneDx Announced as Sequencing Partner for Sunshine Genetics Act Pilot
Oct 14, 2025 • Inside Precision Medicine
GeneDx Q2 2025 presentation: revenue jumps 49%, guidance raised on strong results
Oct 14, 2025 • Investing.com
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
Oct 14, 2025 • Contract Pharma
GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program
Oct 13, 2025 • Business Wire
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
Oct 9, 2025 • Yahoo Finance
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
Oct 9, 2025 • Business Wire
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
Oct 8, 2025 • Business Wire
GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025
Oct 7, 2025 • Business Wire
How the BEACONS Genomic Newborn Screening Initiative Could Shape GeneDx Holdings (WGS) Pediatric Genomics Leadership
Oct 3, 2025 • simplywall.st
GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award
Oct 1, 2025 • Business Wire
GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth
Sep 30, 2025 • Business Wire
GeneDx Appoints Lisa Gurry as Chief Business Officer
Sep 30, 2025 • Contract Pharma
Pediatric rare diseases are often underdiagnosed. GeneDx wants to change that.
Sep 29, 2025 • Medical Marketing and Media
GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference
Sep 25, 2025 • Business Wire
GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors
Sep 18, 2025 • Yahoo Finance
GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors
Sep 18, 2025 • Business Wire
GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors
Sep 18, 2025 • BioSpace
GeneDx Appoints Dr. Thomas Fuchs To Board
Sep 18, 2025 • citybiz
GeneDx Appoints Dr. Thomas Fuchs to its Board of Directors
Sep 18, 2025 • MarketScreener
Opinion | The Genetic Answer to Rare Diseases
Sep 12, 2025 • Technology - WSJ.com
GeneDx at Morgan Stanley Conference: Rare Disease Focus
Sep 8, 2025 • Investing.com
Transcript : GeneDx Holdings Corp. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-08-2025 08
Sep 8, 2025 • MarketScreener
GeneDx (WGS): Valuation in Focus Following Securities Investigation Triggered by Fraud Allegations
Sep 7, 2025 • Yahoo Finance
GeneDx at Wells Fargo Conference: Diagnostic Ambitions
Sep 4, 2025 • Investing.com
GeneDx at Canaccord Conference: Expanding Genomic Horizons
Aug 12, 2025 • Investing.com
GeneDx is Changing Medicine so Families Don’t Have to Suffer Through Years of Uncertainty
Aug 12, 2025 • citybiz
Will GENEDX HOLDINGS (WGS) Gain on Rising Earnings Estimates?
Aug 11, 2025 • Nasdaq
GeneDx Holdings' (NASDAQ:WGS) Performance Is Even Better Than Its Earnings Suggest
Aug 7, 2025 • Yahoo Finance
GeneDx to Participate in Upcoming Investor Conferences
Aug 7, 2025 • BioSpace
GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth (NASDAQ:WGS)
Jul 31, 2025 • Seeking Alpha
Why GeneDx Holdings Stock Crushed It Again Today
Jul 30, 2025 • The Motley Fool
GeneDx Holdings Second Quarter 2025 Earnings: Beats Expectations
Jul 30, 2025 • Yahoo Finance
GeneDx Holdings Stock Keeps Rising. Is It Too Much?
Jul 30, 2025 • StocksToTrade
GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights
Jul 29, 2025 • Yahoo Finance
GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights
Jul 29, 2025 • Business Wire
GeneDx Q2 2025 slides: Revenue surges 49%, company raises full-year guidance
Jul 29, 2025 • Investing.com
Stamford-based GeneDx tops $100M in revenue in Q2, posts 4th straight profitable quarter
Jul 29, 2025 • Hartford Business Journal
Why GeneDx Holdings Stock Blasted 8% Higher Today
Jul 29, 2025 • The Motley Fool
GeneDx Swings to Q2 Adjusted Earnings as Revenue Increases; Fiscal 2025 Revenue Outlook Raised
Jul 29, 2025 • MarketScreener
GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights
Jul 29, 2025 • BioSpace
GeneDx Q2 Revenues Grow 49 Percent Driven by the Genome, Exome Testing
Jul 29, 2025 • GenomeWeb
GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights
Jul 29, 2025 • Morningstar.com
UPDATE: GeneDx Raises 2025 Revenue Guidance, Eyes General Pediatrics for Further Growth
Jul 29, 2025 • GenomeWeb
Why GENEDX HOLDINGS (WGS) Could Beat Earnings Estimates Again
Jul 28, 2025 • Yahoo Finance
Genetic Testing Market to Soar to $54.2B by 2033, Driven by Personalized Medicine and Tech Innovation
Jul 28, 2025 • EIN Presswire
Next-Gen Sequencing Market to Reach $35.9B by 2033, Driven by Diagnostics, Innovation & Global Demand
Jul 28, 2025 • EIN Presswire
GeneDx Holdings Corp. (NASDAQ:WGS) Is Expected To Breakeven In The Near Future
Jul 24, 2025 • simplywall.st
GeneDx Holdings Corp. (WGS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Jul 22, 2025 • Yahoo Finance
GeneDx: Strong Testing Volume And Invaluable Genomic Database (NASDAQ:WGS)
Jul 15, 2025 • Seeking Alpha
GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025
Jul 10, 2025 • Yahoo Finance
GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025
Jul 10, 2025 • Business Wire
GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025
Jul 10, 2025 • Morningstar.com
GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025
Jul 10, 2025 • BioSpace
GeneDx stock initiated with Overweight rating by Piper Sandler
Jul 9, 2025 • Investing.com
GeneDx initiated with bullish view at Piper Sandler, here's why
Jul 9, 2025 • thefly.com
Guggenheim Raises GeneDx (WGS) Price Target, Maintaining a Buy Rating
Jul 3, 2025 • Yahoo Finance
Chromosomal Microarray Market Trends, Analysis, and Forecast 2025-2034 | Rising Demand for Genetic Diagnostics, Integration with Genomic Medicine Drives Innovations and Clinical Use
Jun 30, 2025 • Research and Markets
Why GeneDX Stock Surged Higher This Week
Jun 27, 2025 • The Motley Fool
GeneDx Holdings Corp.'s (NASDAQ:WGS) Profit Outlook
Jun 25, 2025 • Yahoo Finance
GeneDx announces SeqFirst study data on rapid genomic testing in pediatrics
Jun 25, 2025 • thefly.com
GeneDx Holdings (WGS) Moves 19.0% Higher: Will This Strength Last?
Jun 24, 2025 • Yahoo Finance
Why GeneDx, An IBD 50 Stock, Has Skyrocketed 36% Over The Past Two Days
Jun 24, 2025 • Investor's Business Daily
AAP guidance 'another reason to believe' in GeneDx, says Craig-Hallum
Jun 24, 2025 • thefly.com
GeneDx says AAP recommends exome, genome sequencing as tests for children
Jun 24, 2025 • thefly.com
GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability
Jun 23, 2025 • Yahoo Finance
GeneDx stock soars after AAP recommends genome testing as first-tier test
Jun 23, 2025 • Investing.com
GeneDx soars as pediatrics group recommends genome testing for developmental delay (WGS:NASDAQ)
Jun 23, 2025 • Seeking Alpha
GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability
Jun 23, 2025 • Business Wire
Galatea Bio and Fabric Genomics Partner to Deliver Comprehensive Genetic Testing for Common Diseases
Jun 23, 2025 • MarketScreener
GeneDx Holdings: A More Reasonable Valuation (NASDAQ:WGS)
Jun 20, 2025 • Seeking Alpha
Possible Bearish Signals With GeneDx Holdings Insiders Disposing Stock
May 29, 2025 • simplywall.st
Wall Street Analysts Predict a 32.62% Upside in GENEDX HOLDINGS (WGS): Here's What You Should Know
May 29, 2025 • Yahoo Finance
GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale
May 22, 2025 • BioSpace
GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip
May 20, 2025 • Seeking Alpha
GeneDx shares tumble 40% after InvestingPro’s overvaluation alert By Investing.com
May 14, 2025 • Investing.com
GeneDx: Time To Buy The Dip (NASDAQ:WGS)
May 14, 2025 • Seeking Alpha
GeneDX-PBMC: An adversarial autoencoder framework for unlocking Alzheimer's disease biomarkers using blood single-cell RNA sequencing data
May 9, 2025 • ScienceDirect.com
GeneDx completes acquisition of Fabric Genomics
May 8, 2025 • Medical Device Network
GeneDx Announces Completion of Fabric Genomics Acquisition
May 7, 2025 • Business Wire
GeneDx Stock: A Volatile Investment in Genomic Testing
May 2, 2025 • Nanalyze
GeneDx Holdings First Quarter 2025 Earnings: Beats Expectations
May 2, 2025 • Yahoo Finance
Stamford genetic-testing firm GeneDx still searching for tenants to sublet part of HQ, shuttered CT lab spaces
May 2, 2025 • Hartford Business Journal
GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates
Apr 30, 2025 • Yahoo Finance
GeneDx Q1 2025 slides: revenue jumps 42%, raises guidance on Fabric acquisition
Apr 30, 2025 • Investing.com